Patients with chronic neck pain who received acupuncture experienced an alleviation of their symptoms, but not at clinically ...

The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer.

Patients with HER2-positive advanced or metastatic breast cancer received trastuzumab deruxtecan every 3 weeks.

Intermediate-stage hepatocellular carcinoma remains a challenge to treat. The new findings may lead to a new treatment ...

The lack of a disease-free survival benefit with adjuvant durvalumab in early-stage resected non-small cell lung cancer in ...

The findings, in which doublet immunotherapy added to standard FOLFOX chemotherapy did not improve progression-free survival, ...

Despite improvement in pathologic complete response with preoperative chemoradiation, the benefit did not extend to overall ...

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...

Pfizer and Moderna mRNA vaccines are updated to better match currently circulating COVID strains, while the Novavax adjuvant ...

Subcutaneous administration of ocrelizumab was noninferior to intravenous infusion in the phase 3 OCARINA II trial.

Hoping to skirt the slow pace of new drug development, researchers are leaning on AI to uncover fresh uses for known ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.